WeChat Mini Program
Old Version Features

Phase 2 Study Using Minimal Residual Disease-Driven Adaptive Strategy in Newly Diagnosed Multiple Myeloma with Upfront Daratumumab-Based Therapy - First Report from the Maestro Trial

J Christine Ye, Philip Boonstra,Erica L. Campagnaro,Matthew Pianko,Andrew Kin,Larry D Anderson,Brea Lipe,Moshe Talpaz,Jeffrey A. Zonder

Blood（2024）

Cited 0|Views2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined